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Background: Gastrointestinal (GI) toxicity is a common effect following radiation therapy (RT) for prostate cancer.
Purpose of the present work is to compare two Normal Tissue Complication Probability (NTCP) modelling
approaches for prediction of late radio-induced GI toxicity after prostate external beam radiotherapy.
Methods: The study includes 84 prostate cancer patients evaluated for late rectal toxicity after 3D conformal
radiotherapy. Median age was 72 years (range 53-85). All patients received a total dose of 76 Gy to the prostate
gland with daily fractions of 2 Gy. The acute and late radio-induced GI complications were classified according to
the RTOG/EORTC scoring system. Rectum dose-volume histograms were extracted for Lyman-Kutcher-Burman (LKB)
NTCP model fitting using Maximum Likelihood Estimation. The bootstrap method was employed to test the fit
robustness. The area under the receiver operating characteristic curve (AUC) was used to evaluate the predictive
power of the LKB and to compare it with a multivariate logistic NTCP model previously determined.
Results: At a median follow-up of 36 months, 42% (35/84) of patients experienced grade 1-2 (G1-2) acute GI events
while 25% (21/84) of patients developed G1-2 late GI events. The best-estimate of fitting parameters for LKB NTCP
model for mild\moderate GI toxicity resulted to be: D50 = 87.3 Gy, m = 0.37 and n = 0.10. Bootstrap result showed
that the parameter fit was robust. The AUC values for the LKB and for the multivariate logistic models were 0.60
and 0.75, respectively.
Conclusions: We derived the parameters of the LKB model for mild\moderate GI toxicity prediction and we
compared its performance with that of a data-driven multivariate model. Compared to LKB, the multivariate model
confirmed a higher predictive power as showed by the AUC values.
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To predict the normal tissue complication probability
after a radiotherapy (RT) treatment one of the most
well-known and used method is the Lyman-Kutcher-
Burman (LKB) model [1] based on dosimetric data avail-
able from dose-volume histograms.
Several authors have published studies about fitting of
LKB model for radiation induced rectal toxicity and
many of them considered rectal bleeding (G1-2) as* Correspondence: laura.cella@cnr.it
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unless otherwise stated.toxicity endpoint. Burman et al. were the first authors
who computed the model parameters suggesting the
values D50 = 80.0 Gy, m = 0.15, n = 0.12 for late rectal
bleeding [2]. More recently, Rancati et al. [3] have found
D50 = 81.9 Gy, m = 0.19, n = 0.23 and QUANTEC recom-
mended the values D50 = 76.9 Gy, m = 0.13, n = 0.09 to
apply LKB model for the same endpoint [4-6]. While many
studies have been published about NTCP models for late
rectal bleeding, so far very few authors have reported re-
sults about moderate/mild toxicity as high stool frequency,
loose stools and rectal urgency as endpoints [7-10].
The traditional NTCP models use only the dose infor-
mation to predict toxicity. In the last few years severall. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Main clinical data, summary of univariate logistic
regression and correlation coefficient (Rs) with radiation-
induced late gastro-intestinal toxicity incidence
Univariate analysis
Clinical characteristic N % Rs p-value
Age (yrs)
≤70 36 42.9
>70 48 57.1 0.167 0.130
Antihypertensive/anticoagulants
Yes 56 66.7
No 28 33.3 -0.292 0.007
Antihypertensive
Yes 53 63.1
No 31 36.9 -0.242 0.026
Anticoagulants
Yes 34 40.5
No 50 59.5 -0.140 0.204
Acute GI toxicity
Yes 35 41.7
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of rectal injury depending on many individual factors ex-
tracted from clinical information: the drug prescription
(anti-hypertensives and/or anti-coagulants), smoking
history, previous abdominal surgery, pre-treatment mor-
bidities (hypertension, cardiovascular history), diabetes
mellitus, presence of acute gastro-intestinal toxicity
[8,11-15]. Defraene et al. demonstrated the benefit of in-
cluding clinical factors in the predictive power of differ-
ent NTCP models for all the endpoints considered, i.e.
rectal bleeding, high stool frequency and fecal incontin-
ence [8].
In a previous work, we derived a multivariate NTCP
model for late GI toxicity from a set of 57 patients
treated with RT for localized prostate cancer [15] and we
compared its performance with the LKB model using
the parameters suggested in literature [7]. In the present
work we extended the sample size with an additional
dataset up to 84 patients in order to: 1) fit the LKB
model deriving the parameters for specific rectal toxicity;
2) validate the multivariate model on an extended cohort
of patients and compare its predictive power with the
LKB model.
Methods
Clinical and dosimetric data
We retrospectively analyzed the treatment plans of 99
consecutive patients affected by localized prostate
adenocarcinoma treated with radiotherapy at the radi-
ation oncology department of the University “Federico
II” of Naples. Data of radiation-induced rectal toxicity
and treatment characteristics were obtained from clinical
reports and matched with the dosimetric data. All par-
ticipants gave written informed consent and the patient
data were analyzed anonymously. This retrospective
study was approved by the local Ethics Committee. For
14 out of 99 patients physics and/or follow-up data were
not available while one patient experienced GI disorders
before treatment. These patients were excluded from
further evaluation. Clinical data included cardiac comor-
bidities, smoking history, hormonal therapy, drugs pre-
scription, prostate specific antigen (PSA) at diagnosis.
Dosimetric data were extracted from the cumulative
dose-volume histograms (DVHs).
All patients were treated with full three-dimensional
radiation treatment planning with a total dose of 76 Gy
in 38 daily fractions of 2 Gy. RT was administered with
20 MV photon beams from linear accelerator by con-
formal radiation technique (CRT) with six field ar-
rangement or by conformal dynamic arc radiation
technique (ART). XIO (Elekta CMS) and ERGO (3D-
Line Medical System) treatment planning systems were
used. The above RT techniques are described more in
detail in [15].Treatment planning was based on computed tomog-
raphy (CT) performed with empty rectum, comfortably
filled bladder, and with the patient in prone position
using vacuum-locked mattress. Five-millimeter incre-
ment CT slices of the pelvis extending from L4-L5 to
2 cm caudal to the bottom of ischial tuberosities were
acquired. CT images were electronically transferred to
the CT simulation software (Focal Ease 4.2, Elekta CMS)
for target and critical organs contouring. Clinical target
volume (CTV) included the prostate gland or the pros-
tate gland plus the seminal vesicles. A 1 cm margin was
3D automatically added around the CTV to define the
planning target volume (PTV), except at the boundary
between the anterior rectal wall and the prostate, where
a 0.5 cm margin was used. The rectum delineation was
performed on purpose by the same radiation oncologist
(M.C.) according to the male Radiation Therapy Oncol-
ogy Group (RTOG) Normal Pelvis Atlas [16]. The pre-
scription dose was specified at the center of the PTV.
Field weightings were adjusted to achieve the 95% of
prescription dose to 95% of the PTV.
End point
The definition of acute and late GI toxicity was evalu-
ated according to Radiation Therapy Oncology Group/
European Organization for Research and Treatment of
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Figure 1 Average cumulative rectum DVH for patients who have developed GI toxicity (red line) and for patients who haven’t
developed GI toxicity (black line).
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icity was classified as acute if it occurred during radio-
therapy and in the first 3 months thereafter, while it was
classified as late GI toxicity if present after 3 months
from the completion of treatment. The monitoring of
patients for GI toxicity was part of clinical routine,
follow-up visits were planned every 3 months for the
first year, then every 6 months for the next 3 years, and
yearly thereafter.Statistical analysis and modelling
Univariate logistic analysis was performed using the
Spearman’s rank correlation (Rs) coefficient to assess
correlation of patient clinical data with late GI toxicity.Normal tissue complication probability models
In this study, we have analyzed two NTCP models:
Lyman-Kutcher-Burman (LKB) model and multivariate
logistic NTCP model.
According to LKB model with generalized equivalent
uniform dose (gEUD) formulation, NTCP is expressed



















D50 is the value of the dose corresponding to the 50%
probability to induce normal tissue complication, the
parameter m is inversely proportional to the slope of
dose-response curve, the parameter n can assume values
in the range 0-1 and accounts for volume effect of the
organ; vi is the relative volume that receives the dose di,
the sum is over all the bins of DVH.
The Maximum Likelihood (ML) method was used to
find the best-fit values of the parameters D50, m and n
by maximizing the logarithm of the likelihood (LLH):
LLH D50; m; nð Þ ¼
X
y ið Þ¼1




log 1−NTCP D50; m; nð Þð Þ
ð4Þ
The sum is over all the patients with different outcome
y(i) = 1 and y(i) = 0, i.e. with and without GI toxicity
respectively.
The LLH function was numerically maximized by the
Nelder-Mead Simplex Method (Matlab implementation:
FMINSEARCH function) using an in-house developed
library for Matlab [19].
Ninety-five percent confidence intervals for parame-
ters estimates were obtained using the profile likelihood
method [20]. Following this method, each parameter be-
longing to the set (D50, m, n) was varied around its ML
Figure 2 Likelihood estimation values plotted as a function of rectum LKB parameters: a) m and D50 for fixed value of n = 0.10; b) D50
and n for a fixed value of m = 0.37; c) n and m for a fixed value of D50 = 87.3 Gy; d) NTCP bundle curves showing 95% confidence
interval region fit for the model. Blue points represent the results of bootstrap resample runs.
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were fixed at their ML estimate.
The 95% confidence bounds were determined reducing
the maximum LLH by one half of the χ2 inverse cumula-
tive distribution function associated to 95%, so as to ob-
tain the iso-likelihood contours in each Cartesian plane
of the parameters space (D50, m, n). In correspondence
to the parameters values belonging to the iso-likelihood
contours, a bundle of NTCP curves was calculated and
the 95% confidence region for the model fit was thus
estimated [21].
In order to perform an internal validation of the fitting
results and to test the fit robustness, the bootstrap
method was here employed to determine the spread in
ML estimation of NTCP parameters. The bootstrap re-
sampling method works by refitting the NTCP model
using the ML estimation to many pseudo-datasets whichare created by subsampling the input data set (20000
bootstrap resample runs with a number of folds of 80).
The logistic regression model is based on the sigmoidal
relationship between dose and response endpoint. The
normal tissue complication probability is given by:
NTCP ¼ e
g xð Þ
1 þ eg xð Þ ð5Þ
where x represents a vector of input variables and g(x) is
given by the following equation:
g xð Þ ¼ α þ
Xs
i¼1
βi xi i ¼ 1;…; s ð6Þ
The model order is defined as s, while α and βi are the
corresponding set of model coefficients determined by















Figure 3 Plot of correlation coefficient of LKB NTCP values as a function of the volume fraction of rectum corresponding to the
Dx dose.
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observed outcomes.
Model’s evaluation and comparison
In a previous analysis of the GI toxicity on a subset (57
patients) of the present dataset we developed a 3-
variable logistic regression model consisting of the per-
centage of rectum volume which receives at least a dose
of 65 Gy (V65), the use of antihypertensive and/or anti-
coagulant drugs (AH/AC) and the manifestation of acute
GI toxicity. The expression of g(x) with the values of the
coefficients is given by:
g xð Þ ¼ −1:283 þ 0:028
 V65 − 1:442  AH=AC
þ 1:458  Acute GI toxicity ð7Þ
To assess the correlation of the LKB and the above
multivariate model with GI toxicity the Rs coefficient
was analyzed. To evaluate the discriminating ability of
model fits, the receiver-operating characteristic (ROC)
analysis was performed and the area under the receiver
operating characteristic curve (AUC) was calculated
(SPPS Inc., Chicago IL, vs. 18). The discrimination valueTable 2 AUC values of ROC curves and Spearman’s
correlation coefficient (Rs) of LKB and logistic NTCP
models with 95% confidence intervals
Model AUC Rs
LKB 0.60 (0.442, 0.736) 0.133
Logistic 0.75 (0.613, 0.891) 0.378on the ROC curve, i.e. the cut-off point optimally classify-
ing patients in a binary prediction problem, was deter-
mined by Youden’s J statistic [22]. ROC curve comparison
was performed by a Z test.Results
Clinical and dosimetric data were collected for eighty-
four patients of which 42% (35/84) had developed acute
GI toxicity while 25% (21/84) had developed late GI tox-
icity. Among cases of acute rectal morbidity, 74% (26/35)
were G1 and 26% (9/35) were G2. Of note, no cases of late
rectal toxicity greater than grade 1 were reported.
The univariate logistic regression analysis showed a
negative relation between antihypertensive/anticoagulant
treatments and GI late toxicity, while a positive relation
was found between acute GI toxicity and late GI toxicity
(Table 1).
With regard to the dosimetric evaluation, in Figure 1
the mean cumulative rectum DVHs for GI late toxicity pa-
tients and complication-free patients were compared: on
average, the rectal volume irradiated in the dose range of
25-70 Gy for GI late toxicity patients was greater.LKB fitting
The optimal NTCP parameters values for LKB model re-
sulted to be D50 = 87.3 Gy (95% CI 75.9-102.2 Gy), m =
0.37 (95% CI 0.26-0.64), n = 0.10 (95% CI 0.02-0.26) and
the corresponding value of log-likelihood is LLH = -46.3.
Figures 2a-c illustrate the iso-likelihood contours in each
Cartesian plane of the parameters space (D50, m, n). In
Figure 2d the bundle of NTCP curves corresponding to
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plotted.
The optimal parameters were used to calculate the
NTCP values as a function of Dx doses, being Dx the
minimum dose to the x volume. The NTCP values and
the fractional rectal volume were then correlated using
the Rs coefficients (Figure 3).
To test the fit robustness we performed a bootstrap
method. The mean and the standard deviation of LKB
NTCP model parameters obtained for bootstrap samples
are D50 = 87 Gy (SD = 6 Gy), m = 0.37 (SD = 0.08), n = 0.10
(SD = 0.03). The mean values of m and n parameters are
close to the exact fit to the whole patient cohort.
Comparison of the predictive capability of LKB and
logistic NTCP models
In a previous work we suggested a three-variable logistic
NTCP model, including clinical patient-specific factors
[15]. Accordingly, the risk of G1-2 late GI toxicity in-
creased as V65 increased, it was higher for patients ex-
periencing previous acute toxicity and lower for patients
taking antihypertensive and/or anticoagulant drugs.
The model exhibited a good predictive performance
(AUC = 0.79). When applied to the present extended
dataset, the logistic NTCP performance is still good
with an AUC value of 0.75 (95% CI 0.613-0.891).Figure 4 ROC comparison. Logistic regression model vs. LKB model foFor comparison, the AUC and Rs values of the multi-
variate logistic and LKB models are reported in Table 2
and the ROC curves are shown in Figure 4.
The discrimination value on the ROC curve for LKB-
NTCP model is 26% and for the logistic NTCP model is
39%. According to LKB model, GI toxicity incidence was
higher in patients with NTCP ≥ 26% than in those with
NTCP < 26% (37.1% vs. 16.3%) (Figures 5.a and b). Ac-
cording to the logistic model GI toxicity occurred more
frequently in the group with NTCP ≥ 39% than in those
with NTCP < 39% (15/27, 55.6% vs. 6/57, 10.5%).
The ROC curve comparison showed a significant
difference in the prediction capability of the two models:
the logistic NTCP resulted in being significantly more pre-
dictive when compared to LKB NTCP (z > 1.96, P < 0.05).
Discussion
In recent years, technological advances in radiation ther-
apy have allowed to deliver higher prescribed dose for
localized prostate cancer [23] and to reduce the risk of
severe adverse effects. Consequently, we are observing a
change in the toxicity profiles of external beam RT and
the focus of toxicity analysis is changing from rectal
bleeding to quality of life assessment [24]. Alterations of
intestinal motility and peristalsis such as high stool fre-
quency, loose stools and rectal urgency can greatly affectr gastrointestinal toxicity.
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quence it is extremely important to model different and
specific aspects of rectal toxicity in a robust way.
Many studies report on LKB normal tissue complica-
tion probability parameters for rectal bleeding [25,26]
while very few data are available on late mild/moderate
radio-induced toxicity for the rectum. Gulliford et al. [7]
have found the LKB parameters for specific rectal com-
plications observed in clinical practice including stool
frequency, loose stools and rectal urgency.
In the present study, we retrospectively reviewed 84
patients undergoing radiotherapy for prostate cancer.
The most frequently observed symptoms were high stool
frequency, loose stools and rectal urgency while no
rectal bleeding was recorded.
Using the mild/moderate rectal late toxicity as endpoint,
two different modelling approaches were compared: the
Lyman-Kutcher-Burman (LKB) and the data-driven multi-
variate logistic NTCP models. We compared the predict-
ive power of the two models to understand the benefits of
a data-driven approach to NTCP modeling.
Indeed in a previous study [15], we have analyzed dosi-
metric and clinical data of a subset of patients (57) with
localized prostate cancer treated with radiation therapyFigure 5 Scatterplot of V65 (%) for the rectum vs. normal tissue comp
and b) respectively). Patients with gastrointestinal (GI) toxicity are plotted
as open black circles. For the LKB model the region with NTCP < 26% had
logistic model the region with a lower incidence of GI toxicity is that downand we have obtained a multivariate normal tissue com-
plication model for the rectum. We compared its pre-
dictive performance with the LKB model using a set of
parameters proposed in the literature [7]. In order to be
fair in comparing two different model philosophies, in
the present study based on an extended cohort, we first
identified the best set of parameters for the LKB model on
our dataset and then we compared its performance with
the logistic NTCP model. Figure 4 shows the better per-
formance of multivariate NTCP model (Rs = 0.378, p < .001,
AUC= 0.751) compared to the LKB NTCP model (Rs =
0.143, p < .001, AUC= 0.595). The obtained results confirm
the importance of including, besides the dose, clinical fac-
tors such as the use of anticoagulant and/or antihyperten-
sive drugs and the appearance of acute toxicity to obtain a
robust prediction of the late toxicity risk. Models that take
into account relationships among different patient-related
and dosimetric factors may offer a powerful approach to
the optimization of risk ascertainment in order to establish
tailored strategies for a patient adapted RT.
Using our cohort of patients, we estimated the best fit
values for the parameters of the traditional LKB model
by the Maximum Likelihood (ML). The LKB fitted par-
ameter values estimated from our cohort resulted to belication probability (NTCP, %) for LKB and logistic models ((a)
as open red circles, the patients free from GI toxicity are represented
a lower incidence of GI toxicity than the rest of the region, while for
NTCP value of 39%.
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result with that of Gulliford et al. for similar endpoints [7]:
the m parameter resulted comparable, while we found dif-
ferent values for D50 and n values. Indeed, Gulliford et al.
report D50 value in the range of 54.1-62.6 Gy, m value in
the range of 0.34-0.6 and n value in the range 0.36-0.40.
Very recently, Ospina et al. [5] found lower n values
(0.003 to 0.06) for all types of late rectal toxicity
(grade ≥ 2) showing the serial behavior of rectum. The
slight differences in NTCP parameters may depend on
several factors, such as the DVH shape, the conformity
of the technique, the dose-volume constraints, the dose
calculation algorithm and the rectal volume definition
[5]. A volume-exponent of n = 0.10 reflects a remark-
able influence of the high-dose region, which is mostly
determined by the shape of the rectum near the pros-
tate. Several studies explore the effects of the setup
error and organ motion on the deviations in the dose
delivery and the predicted complications uncertainty
[27-30]. Of note, in this study no motion-inclusive dose
distribution has been used to take into account the
variation between the planned dose distribution to the
rectum and the treated dose distribution. A recent
study reports the differences in associations for tenes-
mus and rectal bleeding using the planned over the
motion-inclusive dose distributions by a simulations of
random and/or systematic motion to the planned dose
distributions [27]. Except for the uncertainties arising
from setup errors, volume organ variability and con-
touring method, from our results the rectum seems to act
as a more “serial-like” organ. The values of D50 = 87.3 Gy
(CI 95%, 75.9-102.2 Gy) are similar to literature values for
G1-2 rectal bleeding [2,13,31,32] and for stool frequency
and fecal incontinence of more severity grade [9].
We expected that the dose response for mild grade
complications be shifted to lower dose while the dose re-
sponse for severity grade of toxicity be shifted to higher
doses. However, this expectation was not confirmed by
the results. Similarly, Michalski et al. [25] found that the
LKB parameters relative to grade ≥ 3 late rectal bleeding
were broadly similar to those relative to grade ≥ 2 late
rectal bleeding. They attributed this observation to the
deviation of daily rectal position from the position of the
simulation, which would lead to higher cumulative rectal
DVHs than planned.
In this framework, AAPM Task Group 166 suggested
great caution to use phenomenological models as repre-
sentative of radiobiological model of the rectum due to
the complex and different clinical situations from which
they were derived.
An increased dependence on the highest dose for
moderate rectal toxicity of grade 1-2 is in accordance
with a smaller n value [33]. This effect is evidenced in
Figure 2.b. Our results suggest a serially constructedorgan when moderate late toxicity endpoints are consid-
ered. As shown in Figure 3, the correlation coefficient
for the LKB NTCP values decrease as the fractional vol-
ume increases, implying that the high-dose parts of the
patient’s histograms corresponds to a better representa-
tion of the patients’ actual risk. A similar result was
already reported by Dale et al. [34] who observed an
increased correlation coefficient as n decreases.
Conclusions
In this study, we demonstrated that the multivariate
NTCP model deriving from a previous work outper-
formed the LKB model derived from the same set of
patients. In future perspective both models have to be
tested on dose distributions including the changes in
rectum shape based on multiple CT scans. A dose-
volume effect analysis, with and without including rectal
motion, will eventually disclose whether the rectal mo-
tion model improves the prediction of GI toxicity by the
logistic model.
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